BerGenBio ASA (OSL: BGBIO)
Norway flag Norway · Delayed Price · Currency is NOK
10.90
-0.18 (-1.62%)
Aug 30, 2024, 4:25 PM CET

BerGenBio ASA Cash Flow Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-155.41-190.4-302.12-309.36-257.03-199.28
Upgrade
Depreciation & Amortization
0.420.220.881.310.730.79
Upgrade
Stock-Based Compensation
4.843.143.477.117.413.84
Upgrade
Other Operating Activities
-12.26-4.63-0.64-7.51.03-5.2
Upgrade
Change in Accounts Receivable
-3.86-1.62-3.461.831.592.01
Upgrade
Change in Accounts Payable
-9.42-31.8113.643.2711.9811.15
Upgrade
Operating Cash Flow
-175.69-225.1-288.23-303.34-234.29-186.68
Upgrade
Capital Expenditures
-----0.07-
Upgrade
Sale of Property, Plant & Equipment
0.17-0.3---
Upgrade
Other Investing Activities
2.763.062.953.133.622.21
Upgrade
Investing Cash Flow
2.933.063.253.133.552.21
Upgrade
Long-Term Debt Repaid
--0.19-0.31-0.57-0.59-0.59
Upgrade
Net Debt Issued (Repaid)
-0.4-0.19-0.31-0.57-0.59-0.59
Upgrade
Issuance of Common Stock
147.74262.053.2216.63740.8582.79
Upgrade
Other Financing Activities
-10.12-36.97-0.01-0.07-40.76-4.88
Upgrade
Financing Cash Flow
137.21224.882.916699.5177.32
Upgrade
Foreign Exchange Rate Adjustments
9.692.78-3.76-0.78-0.710.33
Upgrade
Miscellaneous Cash Flow Adjustments
----0--
Upgrade
Net Cash Flow
-25.865.62-285.84-285468.06-106.83
Upgrade
Free Cash Flow
-175.69-225.1-288.23-303.34-234.36-186.68
Upgrade
Free Cash Flow Margin
-33721.11%-63587.85%-74095.37%-39191.21%-38994.51%-2097.56%
Upgrade
Free Cash Flow Per Share
-6.07-15.73-325.18-344.87-312.81-321.70
Upgrade
Cash Interest Paid
-----0.06
Upgrade
Levered Free Cash Flow
-108.99-150.01-176.59-188.09-137.63-112.67
Upgrade
Unlevered Free Cash Flow
-108.99-149.64-176.39-188.05-137.61-112.6
Upgrade
Change in Net Working Capital
12.933.12-10.29-0.06-17.51-10.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.